Cholesterol rich lipid raft microdomains are gateway for acute phase protein, SERPINA1

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 9, 2010, Pages 1562-1570

  Subramaniyam, Devipriya ^a   Zhou, Huiping ^b   Liang, Min ^b   Welte, Tobias ^a   Mahadeva, Ravi ^c   Janciauskiene, Sabina ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Acute phase proteins; Cholesterol; Inflammation; Lipid rafts; SERPINA1

Indexed keywords

ACUTE PHASE PROTEIN; CD36 ANTIGEN; CHOLESTEROL; FILIPIN; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE; NYSTATIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SERPINA1 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ALPHA 1 ANTITRYPSIN; COMPLEMENT COMPONENT C3B RECEPTOR; SERPINA1 PROTEIN, HUMAN;

ARTICLE; CELL MEMBRANE; ELECTROPHORESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID RAFT; MICROSCOPY; MONOCYTE; PROTEIN INTERACTION; PROTEIN LOCALIZATION; WESTERN BLOTTING; CELL CULTURE; CELL LINE; GENETICS; METABOLISM;

ALPHA 1-ANTITRYPSIN; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; CHOLESTEROL; ELECTROPHORESIS; HUMANS; MEMBRANE MICRODOMAINS; MONOCYTES; RECEPTORS, COMPLEMENT 3B;

EID: 77955093586     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.06.009     Document Type: Article

References (43)

1. Aldonyte R., Hutchinson T.E., Jin B., Brantly M., Block E., Patel J., et al. Endothelial alpha-1-antitrypsin attenuates cigarette smoke induced apoptosis in vitro. COPD 2008, 5:153-162.
2. Andersson L., Bostrom P., Ericson J., Rutberg M., Magnusson B., Marchesan D., et al. PLD1 and ERK2 regulate cytosolic lipid droplet formation. J Cell Sci 2006, 119:2246-2257.
3. Baird B., Sheets E.D., Holowka D. How does the plasma membrane participate in cellular signaling by receptors for immunoglobulin E?. Biophys Chem 1999, 82:109-119.
4. Chen X., Resh M.D. Activation of mitogen-activated protein kinase by membrane-targeted Raf chimeras is independent of raft localization. J Biol Chem 2001, 276:34617-34623.
5. Feridani A.H., Holmqvist B., Sjogren H.O., Strand S.E., Tennvall J., Baldetorp B. Combined flow cytometry and confocal laser scanning microscopy for evaluation of BR96 antibody cancer cell targeting and internalization. Cytometry A 2007, 71:361-370.
6. Finotti P., Pagetta A. A heat shock protein70 fusion protein with alpha1-antitrypsin in plasma of type 1 diabetic subjects. Biochem Biophys Res Commun 2004, 315:297-305.
7. Fregonese L., Stolk J. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis 2008, 3:16.
8. Furuchi T., Anderson R.G. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem 1998, 273:21099-21104.
9. Gilutz H., Siegel Y., Paran E., Cristal N., Quastel M.R. Alpha 1-antitrypsin in acute myocardial infarction. Br Heart J 1983, 49:26-29.
10. Golub T., Wacha S., Caroni P. Spatial and temporal control of signaling through lipid rafts. Curr Opin Neurobiol 2004, 14:542-550.
11. Janciauskiene S., Eriksson S. In vitro complex formation between cholesterol and alpha 1-proteinase inhibitor. FEBS Lett 1993, 316:269-272.
12. Janciauskiene S., Zelvyte I., Jansson L., Stevens T. Divergent effects of alpha1-antitrypsin on neutrophil activation, in vitro. Biochem Biophys Res Commun 2004, 315:288-296.
13. Janes P.W., Ley S.C., Magee A.I., Kabouridis P.S. The role of lipid rafts in T cell antigen receptor (TCR) signalling. Semin Immunol 2000, 12:23-34.
14. Ji S.R., Ma L., Bai C.J., Shi J.M., Li H.Y., Potempa L.A., et al. Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains. FASEB J 2009, 23:1806-1816.
15. Johnson W.J., Kilsdonk E.P., van Tol A., Phillips M.C., Rothblat G.H. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII. J Lipid Res 1991, 32:1993-2000.
16. Kim K.J., Lee O.H., Lee B.Y. Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes. Life Sci 2010, 86:791-797.
17. + transport in vitro and in vivo. Am J Respir Cell Mol Biol 2009, 41:261-270.
18. Lee N.Y., Ermakova S.P., Choi H.K., Kusaykin M.I., Shevchenko N.M., Zvyagintseva T.N., et al. Fucoidan from Laminaria cichorioides inhibits AP-1 transactivation and cell transformation in the mouse epidermal JB6 cells. Mol Carcinog 2008, 47:629-637.
19. Lewis E.C., Shapiro L., Bowers O.J., Dinarello C.A. Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci USA 2005, 102:12153-12158.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
21. Mansfield P.J., Hinkovska-Galcheva V., Borofsky M.S., Shayman J.A., Boxer L.A. Phagocytic signaling molecules in lipid rafts of COS-1 cells transfected with FcgammaRIIA. Biochem Biophys Res Commun 2005, 331:132-138.
22. Mc F.A. Efficient trace-labelling of proteins with iodine. Nature 1958, 182:53.
23. Mendez A.J., Oram J.F., Bierman E.L. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem 1991, 266:10104-10111.
24. Namgaladze D., Kollas A., Brüne B., Oxidized LDL attenuates apoptosis in monocytic cells by activating ERK signaling. J Lipid Res 2008, 49:58-65.
25. Nita I., Hollander C., Westin U., Janciauskiene S.M. Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release. Respir Res 2005, 6:12.
26. Oram J.F. Effects of high density lipoprotein subfractions on cholesterol homeostasis in human fibroblasts and arterial smooth muscle cells. Arteriosclerosis 1983, 3:420-432.
27. Perlmutter D.H., Joslin G., Nelson P., Schasteen C., Adams S.P., Fallon R.J. Endocytosis and degradation of alpha 1-antitrypsin-protease complexes is mediated by the serpin-enzyme complex (SEC) receptor. J Biol Chem 1990, 265:16713-16716.
28. Petrache I., Fijalkowska I., Medler T.R., Skirball J., Cruz P., Zhen L., et al. Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 2006, 169:1155-1166.
29. Phillips M.C., Gillotte K.L., Haynes M.P., Johnson W.J., Lund-Katz S., Rothblat G.H. Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes. Atherosclerosis 1998, 137(Suppl.):S13-17.
30. Poller W., Willnow T.E., Hilpert J., Herz J. Differential recognition of alpha 1-antitrypsin-elastase and alpha 1-antichymotrypsin-cathepsin G complexes by the low density lipoprotein receptor-related protein. J Biol Chem 1995, 270:2841-2845.
31. Rodenburg K.W., Kjoller L., Petersen H.H., Andreasen P.A. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor. Biochem J 1998, 329:55-63.
32. Simons K., Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000, 1:31-39.
33. Slaughter N., Laux I., Tu X., Whitelegge J., Zhu X., Effros R., et al. The flotillins are integral membrane proteins in lipid rafts that contain TCR-associated signaling components: implications for T-cell activation. Clin Immunol 2003, 108:138-151.
34. Smart E.J., Anderson R.G. Alterations in membrane cholesterol that affect structure and function of caveolae. Methods Enzymol 2002, 353:131-139.
35. Sohrab S., Petrusca D.N., Lockett A.D., Schweitzer K.S., Rush N.I., Gu Y., et al. Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium. FASEB J 2009, 23:3149-3158.
36. Subramaniyam D., Virtala R., Pawlowski K., Clausen I.G., Warkentin S., Stevens T., et al. TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin. Int J Biochem Cell Biol 2008, 40:258-271.
37. Tilg H., Vannier E., Vachino G., Dinarello C.A., Mier J.W. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med 1993, 178:1629-1636.
38. Uittenbogaard A., Shaul P.W., Yuhanna I.S., Blair A., Smart E.J. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem 2000, 275:11278-11283.
39. Warnock D.E., Roberts C., Lutz M.S., Blackburn W.A., Young W.W., Baenziger J.U. Determination of plasma membrane lipid mass and composition in cultured Chinese hamster ovary cells using high gradient magnetic affinity chromatography. J Biol Chem 1993, 268:10145-10153.
40. Wu L., Gonias S.L. The low-density lipoprotein receptor-related protein-1 associates transiently with lipid rafts. J Cell Biochem 2005, 96:1021-1033.
41. Yoon I.S., Chen E., Busse T., Repetto E., Lakshmana M.K., Koo E.H., et al. Low-density lipoprotein receptor-related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway. FASEB J 2007, 21:2742-2752.
42. Zeng Y., Tao N., Chung K.N., Heuser J.E., Lublin D.M. Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1. J Biol Chem 2003, 278:45931-45936.
43. Zhu D., Xiong W.C., Mei L. Lipid rafts serve as a signaling platform for nicotinic acetylcholine receptor clustering. J Neurosci 2006, 26:4841-4851.